File(s) not publicly available
From Evidence to Theory: Neo-Liberal Corporate Bias as a Framework for Understanding UK Pharmaceuticals Regulation ¿ Response to Alison Edgley
journal contribution
posted on 2023-06-07, 19:18 authored by John AbrahamThis paper elaborates on Abraham's thesis of 'neo-liberal corporate bias' as an account and explanation of UK medicines regulation. It is argued that Edgley is wrong to represent the thesis as explaining regulatory change solely by reference to the interests of the pharmaceutical industry. On the contrary, it is demonstrated that the theory incorporates the role of the interests of the state, particularly in connection with budgetary savings within the national health-care system. Following on from this, it is shown that, far from disproving the thesis, as Edgley contends, the case of statins switching in the UK is actually entirely predictable from the theory, although not necessarily because Edgley's account of statins switching is correct.
History
Publication status
- Published
Journal
Social Theory and HealthISSN
14778211Publisher
Palgrave MacmillanExternal DOI
Volume
5Page range
161-175Pages
15.0Department affiliated with
- Sociology and Criminology Publications
Full text available
- No
Peer reviewed?
- Yes